Clinical Trials Logo
  1. Home
  2. Severe Alcoholic Hepatitis
  3. NCT01820208

Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

Severe Alcoholic Hepatitis Clinical Trial

Official title:
Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis. - A Double Blind Randomized Control Trial.

Clinical Trial Summary

After successful screening, first the investigators first treat patients of severe alcoholic hepatitis with steroids for 7 days. Patients who are found to be unresponsive as per Lille's score [>0.45] would be randomized into either placebo group or G-CSF group. Responders to steroids will continue on steroids for 28 days followed by 2 weeks of tapering. Non responders will be randomized to receive G-CSF for 28days.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01820208
Study type Interventional
Source Institute of Liver and Biliary Sciences, India
Contact
Status Completed
Phase N/A
Start date March 1, 2014
Completion date June 1, 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04106518 - Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease
Not yet recruiting NCT06155760 - Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis N/A
Completed NCT02808663 - Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis N/A
Withdrawn NCT03087968 - Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 Early Phase 1
Not yet recruiting NCT02485106 - Rifaximin Use in Severe Alcoholic Hepatitis Phase 3
Recruiting NCT03827772 - Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term Outcome N/A
Completed NCT01801332 - Intensive Enteral Nutrition and Acute Alcoholic Hepatitis N/A
Recruiting NCT04103840 - Invasive Fungal Infections in Severe Alcohol-associated Hepatitis
Active, not recruiting NCT03091010 - A Comparison of Fecal Microbiota Transplantation and Steroid Therapy in Patients With Severe Alcoholic Hepatitis. N/A
Completed NCT02161653 - Metadoxine as a Therapy for Severe Alcoholic Hepatitis Phase 4